Although 89.5% of thyroid papillary carcinomas show positive expression of S100A2 in vivo [51], the detailed prognostic impact of S100A2 in thyroid papillary carcinoma remains unclear. Here, S100A2 is linked to thyroid gland papillary carcinoma.